Replicate Bioscience, Inc.
San Diego, California, United StatesPurpose
To develop and evaluate a multigene RNA vaccine candidate for tuberculosis, generating preclinical data to support advancement toward an affordable and accessible vaccine for populations disproportionately affected by the disease.
Grantee
Division
Global Health
Date
MAY 2026
Region served
GLOBAL
Committed amount
$2,743,101
Grant topic
Vaccine Development
Duration (months)
26
Grantee location
San Diego, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.